ACCESS-SMC: Achieving catalytic expansion of seasonal malaria chemoprevention in the Sahel

Objectives

ACCESS-SMC was launched to overcome barriers to SMC scale-up, supporting national malaria control/ elimination programmes (NMCPs) in Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria and The Gambia.

The project aimed to provide up to 30 million SMC treatments to 7.5 million children under five per year for two years, preventing millions of cases of malaria and helping to avert many thousands of deaths. This would require rapidly expanding the global supply of quality-assured and child-friendly SMC treatments, which would be achieved by significantly increasing predictable demand through feasible, acceptable and affordable implementation of SMC owned by national governments.

ACCESS-SMC is working to address the barriers to SMC implementation, and so dramatically increase the number of children receiving this lifesaving intervention.

Taking a market shaping approach, the project works to overcome bottlenecks to both supply of, and demand for, SMC drugs and to improve information flows between the two.